| Balance Sheets | 2025-09-30 | 2025-06-30 | ||
|---|---|---|---|---|
| Cash and cash equivalents | 6,704 | 4,082 | ||
| Marketable securities | 73,454 | 28,592 | ||
| Restricted cash | 54 | 53 | ||
| Prepaid expenses and other current assets | 573 | 164 | ||
| Total current assets | 80,785 | 32,891 | ||
| Property and equipment, net | 78 | 75 | ||
| Operating right-of-use assets | 897 | 165 | ||
| Total assets | 81,760 | 33,131 | ||
| Accounts payable | 509 | 503 | ||
| Lease liabilities | 297 | 102 | ||
| Accrued liabilities | 2,128 | 2,122 | ||
| Total current liabilities | 2,934 | 2,727 | ||
| Long-term lease liabilities | 602 | 47 | ||
| Total liabilities | 3,536 | 2,774 | ||
| Common stock 0.01 par value 120,000,000 and 60,000,000 shares authorized as of september 30, 2025 and december 31, 2024, respectively 65,833,556 and 19,399,513 shares issued and outstanding as of september 30, 2025 and december 31, 2024, respectively | 659 | 380 | ||
| Additional paid-in capital | 178,187 | 127,022 | ||
| Accumulated deficit | -100,622 | -97,045 | ||
| Total shareholders equity | 78,224 | 30,357 | ||
| Total liabilities and shareholders equity | 81,760 | 33,131 | ||
Microbot Medical Inc. (MBOT)
Microbot Medical Inc. (MBOT)